Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
Objective To establish the non-inferior efficacy of vonoprazan versus lansoprazole in the treatment of Asian patients with erosive oesophagitis (EO). Design In this phase III, double-blind, multicentre study, patients with endoscopically confirmed EO were randomised 1:1 to receive vonoprazan 20 mg o...
Main Authors: | Xiao, Yinglian, Zhang, Shutian, Dai, Ning, Fei, Guijun, Goh, Khean Lee, Chun, Hoon Jai, Sheu, Bor Shyang, Chong, Chui Fung, Funao, Nobuo, Zhou, Wen, Chen, Minhu |
---|---|
Format: | Article |
Published: |
BMJ Publishing Group
2019
|
Subjects: |
Similar Items
-
Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial
by: Yinglian Xiao, et al.
Published: (2024-04-01) -
The role of vonoprazan in patients with erosive esophagitis
by: Mengyu Zhang, et al.
Published: (2022-09-01) -
Vonoprazan in the management of erosive oesophagitis and peptic ulcer-induced medication: a systematic review
by: Décio Chinzon, et al.
Published: (2021-12-01) -
Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis
by: Ken Haruma, et al.
Published: (2023-05-01) -
Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial
by: Daisuke Kawai, et al.
Published: (2021-05-01)